Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine.

Taïeb, David; Fargette, Christelle; Jha, Abhishek; Pacak, Karel

Taïeb, David; Fargette, Christelle; Jha, Abhishek; Pacak, Karel.

Afiliação

Taïeb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Fargette C; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Jha A; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Pacak K; Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Endocr Relat Cancer ; 30(4)2023 04 01.

Article em En | MEDLINE | ID: mdl-36633962

Assuntos

Neoplasias das Glândulas Suprarrenais; Medicina Nuclear; Paraganglioma; Feocromocitoma; Humanos; Medicina de Precisão

Palavras-chave

neuroendocrine tumors; precision medicine; somatostatin receptor; targeted radionuclide therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais / Medicina Nuclear Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google